Replies to post #89486 on Amarin Corp Plc (AMRN)

[Nukemtiltheyglow]

YB; I see your point about Medivation (MDVN) being similar to Amarin. Although a Cancer Drug company. A watershed event occurred on Nov. 2, 2011. MDVN stock went from 4.30 to 11 the following day. MDVN revs in 2013 were about $243M annual, Amarin is quickly approaching $130. MDVN has (3) drugs, AMRN has one drug with the potential of many more.

Amarin's watershed event is coming soon...... MDVN has 96% Institutional ownership with many deals pending, they are in a bidding war. I'm not concerned with Amarin's longevity in the market, I'm just concerned with my own ability to keep my hand off the sell button. Based upon MDVN success which I can see the same in store for Amarin. I want to retire and do something else with my life, it will be very hard to hold on for 5 more years is my guess for Amarin to get to $120.

Thanks for posting that analogy

Nuke

[Biobillionair]

A Medivation BO would be around an $11 Billion...Sales are close to $1 Billion.

A RI indication lands "V" above a $100 Billion lifecycle. 2.3 million scripts per month is less than a 5% market penetration for RI indication, but still sets sales of around $5 billion per year.

I'd expect an Amarin BO to be in the immediate range of $20-30 Billion if RRR =>30%.

We only have another 30-40 days to speculate IMO.

BB